Immucor, Inc. Sustainability Profile
Immucor, Inc., a leading player in the transfusion and transplantation diagnostics industry, is headquartered in the United States. Founded in 1982, the company has established itself as a pioneer in developing innovative solutions for blood banks and hospitals, focusing on immunohematology and molecular diagnostics. With a strong presence in North America, Europe, and Asia, Immucor offers a range of core products, including automated blood typing systems and antibody screening tests, which are distinguished by their accuracy and efficiency. The company’s commitment to advancing patient safety and improving laboratory workflows has solidified its market position, making it a trusted partner in the healthcare sector. Notable achievements include numerous regulatory approvals and a robust portfolio of patented technologies that enhance the reliability of transfusion practices.
DitchCarbon Score
How does Immucor, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Immucor, Inc.'s score of 29 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Immucor, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of reported figures. The company is a current subsidiary of Werfen, S.A., which may influence its climate commitments and emissions reporting. Despite the lack of direct emissions data, Immucor, Inc. is part of a corporate family that may have overarching climate initiatives. However, no specific reduction targets or climate pledges have been documented for Immucor, Inc. at this time. The absence of data suggests that the company may still be in the process of establishing its own emissions reduction strategies or aligning with broader corporate sustainability goals set by Werfen, S.A. As the industry increasingly focuses on climate action, it is essential for Immucor, Inc. to develop and communicate its carbon emissions strategy to align with global standards and expectations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2024 | |
|---|---|
| Scope 1 | 3,271,000 |
| Scope 2 | 1,354,000 |
| Scope 3 | 85,403,000 |
How Carbon Intensive is Immucor, Inc.'s Industry?
How Carbon Intensive is Immucor, Inc.'s Location?
Immucor, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Immucor, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
